AMRX
AMRX
US03168L1052
Amneal Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
6.93B EUR
5.53B EUR
3.97B EUR
3.96B EUR
Enterprise Value
9.02B EUR
8.19B EUR
6.46B EUR
6.37B EUR
Valuation Multiples
Trailing P/E
40.63x
35.13x
32.47x
66.21x
Forward P/E
16.7x
--
--
--
Price to Sales
2.22x
1.77x
1.3x
1.71x
Price to Book
193.3x
167.38x
--
--
EV/Revenue
2.89x
2.63x
2.12x
2.74x
EV/EBITDA
13.08x
12.52x
10.2x
14.31x
Price to FCF (P/FCF)
--
--
21.08x
16.76x
EV/FCF
--
--
34.37x
26.93x
FCF Yield
-1.66%
-0.22%
4.74%
5.97%
ende